A Scottland-based %Biotech company is finding a tremendous amount of success so far during Tuesday’s session after the company announced it entered into a research planning collaboration with Dr. Carlos Maluquer de Motes for the development of a treatment for Monkeypox.
Traders were quick to buy up shares of %TCBioPharm (Holdings) plc (Nasdaq: $TCBP) following the announcement, with shares of this micro cap quickly reaching up to $3.8799/share (+70.92%) at the early session high. This move could be indicative of this stock finally finding support for the first time in quite some time.
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.
COMTEX_459028005/2848/2024-10-22T13:50:45
